The Investigation of Cerebral Microstructure Changes of Pediatric Patients  With Type Ⅰ Gaucher Disease Using Diffusion Kurtosis Imaging
Huiying Kang1, Ningning Zhang, Kaining Shi2, Yanqiu Lv1, Di Hu1, and Yun Peng1

1Imaging center, Beijing Children’s Hospital, Capital Medical University, Beijing, China, People's Republic of, 2Imaging Systems Clinical Science, Philips Healthcare, Beijing, China, People's Republic of

Synopsis

Increasing clinical studies suggested that there are some type Ⅰ Gaucher disease (GDⅠ) patients suffering neurological symptom, which was originally defined as non-neuropathlogical involved. This study recruited 38 patients and 32 normal children to investigate morphological changes of brain in GDⅠ patients by using Diffusion Kurtosis Imaging. Our results showed significant decreased MD in bilateral olfactory gyrus, increased MD in right calcarine and substantia nigra and significant increased MK in right olfactory gyrus. Our study suggests a necessity of adjusting the opinion regarding the CNS-involvement of GDⅠ, and DKI analysis is a potential imaging marker in clinical studies of GDⅠ.

Purpose

Gaucher disease is a common genetic lysosomal storage disorder which results from a deficiency of the lysosomal enzyme glucocerebrosidase. Traditionally, brain was deemed as spared in patients of type Ⅰ Gaucher disease. However, a few recent work has reported that more than 36% to 49% type Ⅰ Gaucher disease patients suffering at least one neurological symptom 1,2.Parkinson disease or parkinsonian symptoms have also been reported as an incidental association with type Ⅰ Gaucher disease recently 3. Moreover, an autopsy study has observed astrogliosis in cerebral cortical layers 3 and 5, hippocampal CA2-4, and layer 4b in type Ⅰ Gaucher disease patients 4. It has been suggested that Gaucher disease’s neuropathology process should be considered as a continuum phenotype, rather than a discrete predefined classification 5 .In this work, Diffusion Kurtosis Imaging (DKI) was used to investigate the potential morphological change in hippocampal, olfactory gyrus, calcarine and substania nigra of type Ⅰ Gaucher disease patients, according to the previous findings 4,6 .

Methods

38 type Ⅰ Gaucher disease children patients and 32 normal children were recruited in this study, with the approve of local IRB. All normal children had no history of neurological or psychiatric illness. MR images were scanned using a 3T Philips Achieva TX scanner. High-resolution anatomical images were acquired using a three-dimensional gradient echo sequence with following parameters: Whole brain coverage, TE/TR =3.8/8.3 ms, FA = 12, slice thickness of 1mm, matrix size = 180×180, FOV=180×200×160. Diffusion Kurtosis images were acquired using a single shot echo planar imaging applied in 15 non-collinear directions and a b-value of 0,1000,2000 s/mm2: TR = 8760 ms, TE = 92 ms, field of view = 224 mm × 224 mm, acquisition matrix = 112 × 112, 70 slices were acquired with a slice thickness of 2.0 mm and no gap.

MD and MK maps were calculated by using the Diffusional Kurtosis Estimator (DKE) (www.nitrc.org/projects/dke). Regions of interest (ROIs) of bilateral olfactory gyrus , calcarine , hippocampus and substania nigra were determined by ALL and TD brodmann areas template. T test was used to detect the group difference of MD and MK value between type Ⅰ Gaucher disease patients and controls. Statistical significance level of P<0.05 was considered as significant.

Result and Discussion

Compared with healthy controls, significant decrease of MD in type Ⅰ Gaucher disease patients was found in the bilateral olfactory gyrus and increases in right calcarine and substantia nigra. Significant increase of MK in type Ⅰ Gaucher disease patients was found in the right olfactory gyrus. The MD and MK changes in olfactory are relevant to maybe the astrogliosis 7 and these changes are compatible with a previous study which reported that patients with Gaucher disease had the significantly lower olfactory function scores than controls 6. The MD changes in right calcarine and substantia nigra are compatible with the previous autopsy study, may be relevant to the neuronal loss.

Conclusion

This preliminary study provides novel evidences for structural abnormalities in type Ⅰ Gaucher disease patients, suggesting a necessity of adjusting the opinion regarding the CNS-involvement of type Ⅰ Gaucher disease. Our findings also suggest that DKI analysis is a potential imaging marker to monitor the brain change in type Ⅰ Gaucher disease.

Acknowledgements

No acknowledgement found.

References

1 Chérin P , Rose C , de Roux-serratrice C et al. The neurological manifestations of Gaucher disease type 1:the French Observatoire on Gaucher disease (FROG) J Inherit Metab Dis. 2010;33(4):331-338

2 Giraldo P, Capablo JL, Alfonso P, et al.Neurological manifestations in patients with Gaucher disease and their relatives, it is just a coincidence? J Inherit Metab Dis. 2011 ;34(3):781-787

3 Bultron B, Kacena K, Pearson D,et al. The risk of Parkinson’s disease in type 1 Gaucher disease J Inherit Metab Dis 2010 ;33(2):167-73.

4 Wong K, Sidransky E, Verma A et al Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab 2004 ;82(3):192-207.

5 Capablo JL, Saenz de Cabezón A, Fraile J, et al. Neurological evaluation of patients with Gaucher disease diagnosed as type 1.JNeurol Neurosurg Psychiatry. 2008;79(2):219-22.

6 McNeill A1, Duran R, Proukakis C, et al Hyposmia and cognitive impairment in Gaucher disease patients and carriers. Mov Disord. 2012 Apr;27(4):526-32

7 Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol 2010; 119:7–35

Figures

Table 1. The MD values in the different ROI

Table 2. The MK values in the different ROI

Fig 1 Examples of the regions of interest



Proc. Intl. Soc. Mag. Reson. Med. 24 (2016)
3498